Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional

Phase 2b Multicenter, Randomized, Double-Blind, Placebo- and Active-Controlled, Parallel-Group Study to Assess the PD Response and Safety of Three Dose Levels of (PB1023) Injection Following 20 Weeks of Weekly SC Dosing in Adults With T2DM

ClinicalTrials.gov ID: NCT01658501

Public ClinicalTrials.gov record NCT01658501. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 12, 2026, 4:40 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Phase 2b Multicenter, Randomized, Double-Blind, Placebo- and Active-Controlled, Parallel-Group Study to Assess the Pharmacodynamic Response and Safety of Three Dose Levels of (PB1023) Injection Following 20 Weeks of Once-Weekly Subcutaneous Dosing in Adult Subjects With Inadequately Treated Type 2 Diabetes Mellitus

Study identification

NCT ID
NCT01658501
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
PhaseBio Pharmaceuticals Inc.
Industry
Enrollment
593 participants

Conditions and interventions

Interventions

  • 100 mg PB1023 Drug
  • 50 mg PB1023 Drug
  • 70 mg PB1023 Drug
  • Diet and Exercise Other
  • Metformin Drug
  • Metformin and Sulfonylurea Drug
  • Placebo (0.9% Sodium Chloride) Drug
  • Sulfonylurea Drug
  • Victoza® Drug

Drug · Other

Eligibility (public fields only)

Age range
18 Years to 75 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jun 30, 2012
Primary completion
Jun 30, 2013
Completion
Jun 30, 2013
Last update posted
Dec 6, 2015

2012 – 2013

United States locations

U.S. sites
93
U.S. states
32
U.S. cities
93
Facility City State ZIP Site status
Not listed Anniston Alabama
Not listed Birmingham Alabama
Not listed Gulf Shores Alabama
Not listed Huntsville Alabama
Not listed Mobile Alabama
Not listed Muscle Shoals Alabama
Not listed Chandler Arizona
Not listed Glendale Arizona
Not listed Goodyear Arizona
Not listed Tucson Arizona
Not listed Harrisburg Arkansas
Not listed Little Rock Arkansas
Not listed Searcy Arkansas
Not listed Chula Vista California
Not listed Concord California
Not listed Escondido California
Not listed Hawaiian Gardens California
Not listed La Mesa California
Not listed Los Angeles California
Not listed Oceanside California
Not listed San Jose California
Not listed Santa Rosa California
Not listed Walnut Creek California
Not listed Colorado Springs Colorado
Not listed Denver Colorado
Not listed Stamford Connecticut
Not listed Brandenton Florida
Not listed Brooksville Florida
Not listed Fort Lauderdale Florida
Not listed Hialeah Florida
Not listed Jacksonville Florida
Not listed Miami Florida
Not listed New Port Richey Florida
Not listed Oviedo Florida
Not listed St. Petersburg Florida
Not listed Tampa Florida
Not listed Decatur Georgia
Not listed Marietta Georgia
Not listed Roswell Georgia
Not listed Savannah Georgia
Not listed Boise Idaho
Not listed Arlington Heights Illinois
Not listed Chicago Illinois
Not listed Evansville Indiana
Not listed Indianapolis Indiana
Not listed Council Bluffs Iowa
Not listed Augusta Kansas
Not listed Newton Kansas
Not listed Overland Park Kansas
Not listed Wichita Kansas
Not listed New Orleans Louisiana
Not listed Oxon Hill Maryland
Not listed Ypsilanti Michigan
Not listed Saint Paul Minnesota
Not listed St Louis Missouri
Not listed Fremont Nebraska
Not listed Omaha Nebraska
Not listed Las Vegas Nevada
Not listed Berlin New Jersey
Not listed New Windsor New York
Not listed Rochester New York
Not listed Charlotte North Carolina
Not listed Durham North Carolina
Not listed Hickory North Carolina
Not listed Morehead City North Carolina
Not listed Raleigh North Carolina
Not listed Wilmington North Carolina
Not listed Winston-Salem North Carolina
Not listed Cincinnati Ohio
Not listed Cleveland Ohio
Not listed Delaware Ohio
Not listed Kettering Ohio
Not listed Lyndhurst Ohio
Not listed Wadsworth Ohio
Not listed Willoughby Hills Ohio
Not listed Oklahoma City Oklahoma
Not listed Tulsa Oklahoma
Not listed Eugene Oregon
Not listed Greer South Carolina
Not listed Spartanburg South Carolina
Not listed Austin Texas
Not listed Corpus Christi Texas
Not listed Dallas Texas
Not listed Houston Texas
Not listed Hurst Texas
Not listed Katy Texas
Not listed Magna Utah
Not listed West Jordan Utah
Not listed Burke Virginia
Not listed Richmond Virginia
Not listed Virginia Beach Virginia
Not listed Renton Washington
Not listed Kenosha Wisconsin

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT01658501, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Dec 6, 2015 · Synced May 12, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT01658501 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →